The results of a recent study suggest that the safety profile of a microfocused ultrasound system with visualization (MFU-V), combined with other aesthetic products, are consistent with the safety profiles of the individual treatments. MFU-V is currently indicated for use as a noninvasive dermatological aesthetic treatment to lift the eyebrows, lax submental and neck tissue, and improve lines and wrinkles of the décolleté. Researchers conducted a retrospective chart review of 101 subjects (96 female; 25 to 70 years old). All received MFU-V, 18% received botulin toxin injections, and 81% were treated with temporary and/or semi-permanent dermal fillers within 6 months of treatment of MFU-V in the same of different anatomic areas. They found:

• 7 adverse events (7%) were reported: bruising/purpura (n=4), swelling (n=1), paresthesia (n=1), and herpes simplex virus (HSV) outbreak (n=1).

• Only the HSV outbreak was considered to be related to combined treatments.

Citation: Fabi SG, Goldman MP, Mills DC, Werschler WP, et al. Dermatol Surg. 2016;42,Suppl 2;S168-76. Dermatol Surg. doi:10.1097/DSS.0000000000000751.